Exploring the molecular mechanisms of comorbidity between autism spectrum disorder and sleep disturbances through multi-dataset integration.

Researchers studied the genetic links between autism and sleep problems by analyzing gene expression data. They found a specific gene called LAMC3 that appears important in both conditions and is involved in brain development. The study also identified immune system differences and potential genetic regulators that could be targets for future treatments. This research helps explain why sleep problems are so common in autism.

This bioinformatics study integrated gene expression datasets to explore molecular mechanisms linking autism spectrum disorder (ASD) and sleep disturbances. Researchers analyzed genetic data using differential gene expression analysis, functional enrichment analysis, and weighted gene co-expression network analysis. The study identified LAMC3 as a key gene common to both conditions, playing a crucial role in neural development and associated with cortical malformations. Functional analysis revealed associations with oxidative stress, neurodevelopment, and immune responses.

The researchers also identified potential regulatory microRNAs, including hsa-miR-140-3p.1, and found differences in immune cell proportions between ASD and control groups. The findings suggest LAMC3 as a potential therapeutic target for both conditions.

The identification of LAMC3 as a potential common pathway for ASD and sleep disturbances provides a new research direction. However, these bioinformatics findings require experimental validation and clinical trials before therapeutic applications. The immune system connections suggest potential for immunomodulatory interventions.

This is a bioinformatics study using existing datasets without experimental validation. Sample sizes are not reported. The findings require experimental confirmation and clinical validation before therapeutic applications can be considered.

Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder characterized by social interaction impairments and repetitive behaviors, often accompanied by sleep disturbances (SD). Despite extensive research, the molecular mechanisms underlying the co-occurrence of ASD and SD remain unclear. This study integrated gene expression data from the GEO database for ASD and SD. We performed differential gene expression analysis, functional enrichment analysis, and weighted gene co-expression network analysis (WGCNA) to identify key genes and pathways associated with both conditions.

Additionally, we explored the potential regulatory roles of microRNAs (miRNAs) and transcription factors, and evaluated the therapeutic potential of drug repositioning using the CMap database. We identified LAMC3 as a common key gene in both ASD and SD, which plays a crucial role in neural development and is associated with cortical malformations. Functional enrichment analysis revealed significant associations with processes like oxidative stress, neurodevelopment, and immune responses. The miRNA-LAMC3 regulatory network highlighted several potential miRNAs, including hsa-miR-140-3p.1, which showed strong regulatory effects on LAMC3 expression.

Immune infiltration analysis indicated significant differences in immune cell proportions between ASD and control groups, with LAMC3 positively correlated with certain immune cells. Our findings provide insights into the molecular links between ASD and SD, emphasizing the role of LAMC3 and its potential as a therapeutic target. The identified miRNAs and transcription factors offer new avenues for understanding the pathophysiology of these conditions. Further experimental validation and clinical trials are warranted to explore the therapeutic potential of identified compounds and to develop effective interventions for ASD and SD.